2 курс / Микробиология 1 кафедра / Доп. материалы / Амирджахан_Н_А_Методики_превентивного,_профилактического,_эпидемиологического

151

132.Cohen, C. Patogenesis of chlamydia inguced pelvis in flammatory disease /C. Cohen, R. Brunham // ИППП. - 1999.- № 6.- C. 4-7.

133.Cothch, M. Trichomonas vaginalis associated with low birth weight and pretem deliver /M. Cothch// Nat Inst of Allergy and Infections Diseases, Bethesda, Maryland, USA, Sex Transm. Dis, 1997 - Iul; 24 (6) : 353-360.

134.Danielson, D. Gonourhoeae /D. Danielson // 7n Anglo-Scandinavian Congress on Sexually Transmitted Diseases - London Royal Society of Medicine Services LTD, 1978; 25.

135.Dajek, Z. Azitromycin in the treatment of Chlamydia trachomatis infections/ Z. Dajek // Warsaw Medical School, Poland III Int.Conf on the Macrolides, Azalides Streptogramins, Lisbon, Portugal, Ian 24-26, 1996, Abstr, 1996: 25.

136.Developing a nationwide public servise advertising on STD syndromes / K. Cabal [et al.]// 2 F Biag, 78-80 Polaris E, Jupiter, Ber – Air 2, Makati City 1200. 12 th World ATDS Conf Geneva, Jule 28 – Jule 3, 1998: 679.

137.Defection of Chlamydia trachomatis in asemptomatic Women: relationship to history, contraception and cervicitis /J. Bontis [et al.]// Department of Obstetrics and Gynecology, Aristjtelian University of the Saloniki, Ady Contracept, 1994, Dec.: 10 (4): 309-315.

138.Diagnosis of Chlamydia trachomatis infections in men and women by Festing First – Void urine by Legase Chain Reactions/N. Сhernesky [et al.]//J.Clin microbial, 1994, Nov, 32(11): 2682-85.

139.Djajakusumah, T. Evaluation of syndromie patient management algorithm for urethal disharge/ T. Djajakusumah // Dept of Dermatol, Univ of Antwerpen, Belgium. Int Gongr STD, 12 th Meet I SSTDO, 14 th Red Meet I USII, 1977, Seville, Spain, Progr 0, Abctr 1997 : 79.

140.Does measured behavion chamnge reflect in STD /T. Peterman [et al.] // HTV risk. 1600 Clifton Read NE F – 46, Atlanta,. Georgia 12 th World ATDS Conf Geneva, Iune 28 – Iuly 3, 1998 : 232.

152

141.Drew, R. Azithromycin – spectrum of activity, pharmacokinetics and clinical application/R. Drew, H. Crallis // Pharmacother, 1992; 12:161-73.

142.Dugmore, C. Pharmacoeconomics of single dose azithromycin therapy for chlamydia infections / C. Dugmore,D. Day // Pfzee, Jns, NeW York, N.Y. 111 Jnt Conf on the Macrolides, Azalides, Streptogramins, Lisbon, Portugal, Jan 24-26, 1996 –Abstr., 1996:27.

143.Emergency unit care of sexually transmitted infections /R. Jarvis [et al.] //

Department of Senitourinary Medicine, Manchester Royal Jnbizmary, UK JNT J

STD AIDS, 1998 – Sep; 9 (9): 543 –544.

144.European trends in gonorrhoeae/K. De Schryver [et al.] // Eurosuurveillance Weekly, 2001 : 4.

145.Evaluation of two clinical protocols for the management of women with vaginal discharge in southern Thailand H Dept of Obctetrics – Gynecology, Faculte of Med, Prince of Songkla Univ, Hat Yai, Songkla, thailand /Y. Chandeying [et al.] // Sex Transm, Infect, 1988 – Iun : 74 (3) : 194-201.

146.Evedence – based treatment guidelines for sexually transmitted infections developed with and for female sex workers /F. Behets [et al.] // Tropical Medicint 8 c Jnternational Health 2003 ; 8 : 251-58.

147.Fenton, K. 1 the European Surveilance of Sexually Transmitted Infections (ESSTI). Network /K. Fenton, C. Lowndes // Recent treands in the epidemiology of sexually transmitted infections in the European Union Sex Transm. Infect., 2004 :; 80: 255-263.

148.Fould, G. Selection of dose regimes of azithromycin /G. Fould, R. Johnson //J. Antimicrob Chemother., 1933 ; 31 :39-50.

149.Garnett, S. Sexuall mixing patterns of patients attending STD Clinics /S. Garnett //Sex Transm Dis, 1996; 23: 248-257.

153

150.Guidelines for laboratory diagnosis of Neisseria gonorrhoeae in EastEuropean countries. Part 1: gonorrhea, sampling, and microscopy for diagnosis. / A. Savicheva [et al.] // Acta Medica Lituanica 2007; 4(1):65-74.

151.GrgisVitek, M. Suphilis epidemic in Slovenia influenced by syphilis epidemic in Russion Federation and ather newbyindependent states /M. GrgisVitek, M. Rogl-Butina // Inst. of Public Health of the Republic of Slovenia,

yubljana, Slovenia.Ikt , STD, IDS, 2002; 13 (Supl 2) : 2-4.

152.Haddis, A. The cost effectiveness of azythromycin for Chlamydia trachomatis infections in women/A. Haddis, S. Hillis, W. Kasler // Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA/ Sex Transm. Dis, 1995-Sep-Oct; 22 (5) : 274 –280.

153.Hager ,W. Treatment of Metronidazole - Resistant Trisho monas vaginalis.

155.Herzberg, A. Detection of Trichomonas vaginalis in endocervical and ectocervical smears /A. Herzberg, J. Silver-man // Department of Pathology, East Carolina University School of Medicine, Greenville, NC 27858 – 4354, USA. Diagnost Cytopathol., 1996 May: 14(3); 273-276.

156.Hoffmonn, S. The Laboratory surveillance system of chlamydia trachomatis ana Neisseria gonorrhoeae infections in Denmark /S. Hoffmonn // Euro Surveill, 2001 ; 6: 86 –90.

157.Hook, E. Syphilis control – a continuing challnge /E. Hook, R. Peeling // N. Enge. I. Med., 2004 ; 351 (2) : 122-124.

154

158.Hunt, L. Management of sexually transmitted disease by surgeons. Derbyshire Royal Infirmary, Derby /L. Hunt, I. Nash, G. Dilke Wing // Ann R Coll Surg Engl., 1998 – Sep ; 80 (5) : 356-358.

159.Hunter, H. Epidemiologic and therapeutic data point to opportunities for improved SND control /H. Hunter, M. Golden // W.W.W. medscape, con .

160.In vitro evaluation of activitirs of azithromycin, clarithromycin and sparfloxacin against Chlamydia trachomatis/I. Letevre [et al.] // Phatol Biol, 1993; 41-313-5.

161.Ison, C. Ciprofloxacin as treatment for gonorrhoeae: surveolance of susceptibiliy and emergence of resistange /C. Ison // Dep Med Microbial, JCSM et St Mary s, London, UK Int Congr STD 12t th Meet ISSTDR 8e 14 th Red Meet IUSTI, 1997, Sville, Spain, Progr. 8e Abstr; 1997: 85.

162.Jaffe, H. Selective mass treatment in a venerial disease control program / H. Jaffe, D. Rice , R. Voigt // American Journal of Public Health, 1979; 69: 118782.

163.Johannes, Van Dam. Issuses in STD case management: where are we / Van Dam Johannes //UNAIDS, Geneva, Switzeland, Int Cords STD 12 th Meet ISSTDR 14th Red Meet IUSTI, 1997, Seville, Spain Progr 8e Abstr; 1977:77.

164.Judlin, P. Genital mycoplasmas/P. Judlin // Gynecol. Obstet Fertil, 2003.- Vol.31(11).- P.954-959.

165.Kelly, K. Cellular immunity and Chlamydia genital infection: induction, recruitment, and effector mechanisms/K. Kelly// Int. Rev. Immunol., 2003.Vol. 22.P.3-41.

166.Kirsh, T. Disease surveillance in the ED : factors leading, to the umder reporting of gonorrhoeae / T. Kirsh, R. Shesser, M. Barron // Departament of Emerggence Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA. Am. I. Emerg. Med., 1998 – Mar; 16 (2): 137-140.

167.Kobal, B. Singl-dose azithromycin treatment: the right solution for un complicated lower genital tract chlamydia infection /B. Kobal // University Medical

155

Centre Liubliana, Slovenia. III Int Conf on the Macrolides, Azalides 8e

Streptogramins, Lisbon, Portugal-Jan 24-26, 1996.- Abstr 1996 : 25.

168.Kohl, P. Persistent urethritis: What to do /P. Kohl // Dept of Dermatol and Venerol, Neukolln Hospital, 12351 Berlin, FRG. 6 th Congr EADV 1997 Dublin, Irelana. Abstr IEADV, 1997; 9(1) : 529.

169.Laporoscopy diagnosis of Chlamydial salpingitis using a tubal cytobrush /A. Cianci [et al.] //Ferstil Steril., 1994; (61) 1: 181 –184.

170.Lobro, M.-T. Interference of antibacterial agents with phagocytic functions: immunomodulation or «immune-fairy tales»/ M.-T. Lobro // Clin Microbiol. Rev,2000,13,615-660.

171. Lowndes, C. Тhe ESSTI (European Surveillance of STIs) Network.

Surveillance systems for S T I s in the European Unior: facing a changing epidemiology /C. Lowndes, K. Fenton // Sex Trans. Infect., 2004; 80: 264 –271.

172.Lowndes, C. And the European Surveillance of Sexually Transmitted Infections (ESSTI). /C. Lowndes, K. Fenton // Network, Surveillance Systems for STIs in the European Union : Facing a changing epidemiology. Sex Trancm. Infect. , 2004 ; 80:264 –71.

173.Macrolide Resistange in Treponema pallidum in the United States and Irland. /S. Lukehart [et al.] //N Engl. I. Med., 2004 ; 351 : (2) 154-158.

174.Maintenance of STD control ina mining community following introduction of a targeted intervention/E. Olivier [et al.] // In: Abstracts, International Society for STD Research, Berlin, 2001 : 32 –34.

175.Mardh, P. Notes oncurrently ised public health measures for sexually transmitted diseases /P. Mardh // WNO Collaboration Centre for Sexually Transmitted Diseas and their Complications, Uppsala University, sweden. Sex Transm. Dis., 1994 –MAG – Apr; 21 (2 Suppl) : 90-92.

176.Mathews, C. The senstivity of syndromic management approach in detecting sexually transmitted diseases in patients at a public health clinic in Capetown /C.

156

Mathews, A. Van Rensbirg, N. Coetzee // Centre for Epidemiological Research,

South Africa. S Afr. Med. I., 1998 –-Oct.

177.Mils, W. Physicians practices and opinions regarding prenatal screening for human immunodeficiency virus and other sexually transmitted diseases. Acute Disease Epidemiology Section Minntsota / W. Mils, D. Martin, I. Bertrand // Department of Health, Minneapolis 55440, USA, Sex Transm. Dis., 1998Mart, 25

(3): 169 –175.

178.Mugrditchian, D. Innovative approaches to STD Control. In : G Dallabetta, M Lada, R Lamptey, editors. Control of Sexually Transmitted Diseases: A Handbook for STD Manages. Arlington B A : AIDSCAP / D. Mugrditchian, G. Dallabetta , R. Lamptey // Family Health International, 1996:; 27-31.

179.Mulvey, G. Sexually transmissible diseases – knowbgge and practices of general practitiones in Victoria, Australia /G. Mulvey, M. Temple Smith, L. Keogh // Centre for the studuy of Sexually Transmissible Diseases, Latrobe University, Austtralia , Genitourin Med., 1997 – Dec; 73 (6): :533-537.

180.Opportunity screening of genital infection met Chlamydia trachomatis under the sexual activity evolving in Amsterdam Kostenteffectivite it sanal use in screening bivrouwen /M. Postma [et al.] // Rijksinstitut voor Volksgezondheid en Milieu (RIVM), Centrum Volksgezondheid Toekomst. Verkenningen, Bithoven. Ned. Tijdschr. Geneeskd.. 1999 – Mar 27 ; 143 (13) : 677-681.

181.Over, M. HIV ifection and sexually tuansmitted disesases /M. Over, P. Piot // In : Disease Control Prioritiers in Developing Countries. New York: Oxford University Press ., 1993 : 47-49.

182.Paavonen, J. Pelvic inflammatory diseases – agolal medical emergency/J.

Paavonen // Univ. of Helsinki, Finland. Int Congr STD, 12th Meet ISSTD 14th Red.

Meet IUSTI, 1997 , Seville, Spain Progr Abst 1997: 72.

157

183.Paavonen, J. Pelvic inflamatory disease From diagnosis to prevention /J.

program /J. Paavonen // Department of Obstetrics and Gynecology, University of Helsinki, Findland, IUSTI Europ Congr 1998 on STDs and Genital Dermatol, Goteborg, Sweden, 4-5 September, 1998 :23.

185.Proude, E. Evaluation of a brief general practice – based intervention to reduce STD (sexually transmitted disease) risk behavion among adults age a 18-25 years / E. Proude, I. Ward // CSAHS Needs Assessment and Health Outcomes Urit (NAHOU) Locked Bag N 8 Newtown NSW 2042, Australia. 12 th World AIDS Conf. Geneva, Iune 28 – Iuly.

186.Reddy, P. The learning curve : health education in ST I clinic in South Africa /P. Reddy, A. Meyer Weitz // Medical Research Council, Health Promotion Research and Development Tugerberg, Cape Town, South Africa. Soc. Sci. Med., 1998 – Nov ; 47 (10) : 1445-1453.

187.Renaudin, H. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumonia, Mycoplasma hominis and Ureaplasma urealyticum/ H. Renaudin, C. Bebear // Eur I Elin Microbiol Infect Dis, 1999; 9: 838-41.

188.Resistance of recent Neisseria Gonorrhoeae isolates in Nigeria and outcome of singledose treatment with ciprofloxacin /J. Otubu [et al.] // Infection., 1992 ; 20 (6):339-341.

189.Review of current evidence and comparison of guidelines for effective syphilis treatment in Europe/A. Porkes [et al.] // Int. I. STD a I DS, 2004 ; 15: 73 – 88.

158

190.Ros, J. Is Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment /J. Ros, J. Jensen // Sexually Transmitted Infections 2006; 82 (4): 269-71.

191.Senitourinary medicine services in the United King / T. Djuretic [et al.] // Public Health laboratore Srvice Communicable Disease Surveillance Centre, 61 Colindale Avenue, London NW9 5 Fo, UK, I n t, ISTD ATDS, 2001Sep.; 12 (9): 571-2.

192.Single dose of azithromecin in the treatment of sexually transmitted diseases in infertile and pregnant women/ V. Siminic [et al.] // Medical School University of Zagreb, Chorvatia. PLIVA Pharmacuticals, Zagreb, Chorvatia III hit Conf on the Macrolides, Azalides Streptogramins, Lisbon, Portugal, Jan 24-26, 1996 : Abst 1996:25.

193.Stamm, W. Pathogenesis of pelvis Inflammatory diseases. Seatle, Washngton, USA / W. Stamm // Int. Congr. STD 12th Meet ISSTDR8e14th Red Meet IUSTI, 1997 , Seville, Spain. Prog8e Abstr, 1997:72.

194.STD clinics is an evolving health care environment Demographics, insurance coverage, preferences for STD servicas, and STD morbidity / C. Celum [et al.] //University of Wachington, Seattle USA. Sex Transm Dis, 1997 – Nov: 24 (10) :599: 605.

195.STD syndrome packets: improving syndromie management of sexually. Transmitted diseases in developing countries / D. Wilkinson [et al.] // Centre for Epidemiological Reserch in South Africa, Med Research Council, and Hlabisa Hospital. Sex Trans Dis., 1999.- Mar; 26 (3) : 152-156.

196. Steen, R. The use of epidemiologic mass treatment and syndrome

menagement for sexually transmitted disease control / R. Steen, G. Dallabetta // Family Heath International, Research Triangle Park, North Carolina, USA, Sex. Transm. Dis., 1999 Apr ; 26 (4Suppfl) : S: 12-20; discussion S 21-22.

159

197.Steen, R. Sexually transmitted infection control with sex workers: regular

vulnerability / R. Steen, G. Dallabetta // Reproductive Health Matters, 2003; 11 (

22): 74-90.

198.Stergachis, A. Roles for pharmacists in the prevention and control of sexually transmitted disesases /A. Stergachis // Dept of Pharmacy, School of Pharmacy, Univ of Waschington, Seattle 98195, USA. Sex Transm. Dis., 1999 – Apr; 26 (4 Suppl): S44-47: discussion S 48.

199. Steep, R. The use of epidemiologis mass treatment and syndrome

management for sexually transmitted disease control / R. Steep, G. Dallabetta // Sexually Transm. Dis., 1999; 1\26 (4 / Suppl): S : 12 –S22.

200.Surveillence of antibiotic resistance in Neisseria Gonnorrhoeae in The Neitherlands, 1977-1995 / M. Van de Laar [et al.] //Department for Infections Diseases Epidemiology, Natiomal Institute of Public Health and the Enviroment Bilthoven, Netherlands. Genittourin. Med., 1997-Dec; 73 (6) ; 510-517.

201.Syphilis: old problem, new strategy / L. Doherty [et al.] //BMI, 2002 ; 325 : 153-156.

202.Systematic analysis of STD control: an operational model /P. Rao [et al.] // Sexually Transmitted Infections, 1998 ; 74 (Suppl. l) : S 17 – S22.

203.Targeted mass treatmernt for syphilis with oral azithromycin / M. Rekart [et al.] // lanset, 2003 ; 361 : 313-14.

204.Taylor Seeher, M. Risky sexual behavior among adolescent women / M. Taylor Seeher, L. Rew // I. Soc. Peadiath. Nurs., 2000 =- Ian – Mar; 5 (1) : 15-25.

205.Taylor – Robinson, D. A iourney yhrough time / D. Taylor – Robinson // St. Mary s Hospital, London, UK. Std in a Changing Europe, 13-15 April, 2000, Rotterdam, The Netherlands. Abctracts.

206.Temple Smith, M. Attitudes to taking a sexual history in general practice in Victoria, Australia / M. Temple Smith, G. Mulvey , L. Keogh // Centre for the

160

Study of Sexually Trans. Diss., La Trobe Univi Sex Trans. Infect, 1999 .- Feb;

75(1) : 41-44.

207.Thoumsin, H. L infection dos voies urinaires basses chez la femme. Donnees recentes /H. Thoumsin, R. Lambotte // Department de Gyneggologie – Obstetrigue, Universite de liege, CHR de la Citadelle, Liege. Belgigue, I Gynecol Obstet Biol Reprod (Paris), 1993 ; 22(2);151-156.

208.Treatment delay and reliance on private physicians among patiens with

Sexually transmitted diseases in China/ K. Choi [et al.] // Univ. of California –San

209.Van Doynhoven, Y. The epidemiology of Neisseria gonorrhoeae in Europe / Y. Van Doynhoven // Microbes Infect, 1999 ; I A 55-6A.

210.Van, Dyck. Increasing resistance of Neisseria gonorrhoeae in west and

Trans. Dis., 1997, Jan: 24 (1) : 32-37.

211.Van der Heyden, I. European Study Group. Trends in gonorrhoeae in nine wersten European countries, 1991-6 / I. Van der Heyden, M. Catchpole, A. Paaget Stroobant // Sex Trans. Infect, 2000; 76 : 110-6.

212.Van Kersschaever, S. Trends in gonorrhoea and chlamydia in 10 European networks of STD surveillance between 1991 and / S. Van Kersschaever, I. Van-der Heyden, A. Sasse // Scietific Inst. of Health, Brussels, Belgium. STD in a Chabging Europe. 13-15 April., 2000, Rotterdam, The Netherland. Abctracts.

213.Viberga, I. Characteristics of women at low risk of STI presenting with pelvic inflammatory disease / I. Viberga, V. Odlind , G. Lazdane // Eur J Contracept Reprod Health Care.- 2006.- 11:2:60-68.

214.Visits to emengency departments for gynecologic disorders in the United States, 1992 –1994 / K. Curtis [et al.] // Division of Reproductive Health, Nat Center for Chronic Disease Prevention and Helth Promotion, Centers for Disease Control